Effects of Lactobacillus delbrueckii and Streptococcus thermophillus on tailored triple therapy for Helicobacter pylori eradicatio

Not Applicable

Completed

• Conditions: advert event and number of patients; Helicobacter pylori eradication; tailored triple therapy; probiotic

• Registration Number: TCTR20141209001
• Lead Sponsor: institute of reserch and development, Suranaree University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-12-09
• Study Completion: 2015-06-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Helicobacter pylori associated gastritis

Exclusion Criteria

age below 18 or above 70 years, previous Helicobacter pylori eradication treatment before previous 2 months, gastric ulcer or duodenal ulcer, suspected or confirmed malignancy on endoscopy, significant medical illnesses and history of previous gastric surgery, pregnant or lactating women, and the use of antimicrobials or gastrointestinal medications like PPIs or bismuth compounds within the previous 2 months, refuse yogurt due to underlying disease such as DM ,history of drug allergy in first line therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Administration of probiotic to pre-treatment and post-treatment tailored triple therapy can improve 1 month after treatment eradication rate after complete theraputic protocal

Secondary Outcome Measures

Name	Time	Method
advert event during thraputic peroid 1 month after treatment number and percent of advert event during treatment